JPWO2020130146A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020130146A5
JPWO2020130146A5 JP2020561551A JP2020561551A JPWO2020130146A5 JP WO2020130146 A5 JPWO2020130146 A5 JP WO2020130146A5 JP 2020561551 A JP2020561551 A JP 2020561551A JP 2020561551 A JP2020561551 A JP 2020561551A JP WO2020130146 A5 JPWO2020130146 A5 JP WO2020130146A5
Authority
JP
Japan
Prior art keywords
muscle
improving
muscle quality
agent according
cystine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020561551A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2020130146A1 (ja
JP7548014B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2019/050188 external-priority patent/WO2020130146A1/ja
Publication of JPWO2020130146A1 publication Critical patent/JPWO2020130146A1/ja
Publication of JPWO2020130146A5 publication Critical patent/JPWO2020130146A5/ja
Application granted granted Critical
Publication of JP7548014B2 publication Critical patent/JP7548014B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020561551A 2018-12-21 2019-12-20 筋質向上剤 Active JP7548014B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2018240020 2018-12-21
JP2018240020 2018-12-21
PCT/JP2019/050188 WO2020130146A1 (ja) 2018-12-21 2019-12-20 筋質向上剤

Publications (3)

Publication Number Publication Date
JPWO2020130146A1 JPWO2020130146A1 (ja) 2021-11-04
JPWO2020130146A5 true JPWO2020130146A5 (https=) 2022-12-28
JP7548014B2 JP7548014B2 (ja) 2024-09-10

Family

ID=71101355

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020561551A Active JP7548014B2 (ja) 2018-12-21 2019-12-20 筋質向上剤

Country Status (4)

Country Link
US (1) US20210308084A1 (https=)
EP (1) EP3900718A4 (https=)
JP (1) JP7548014B2 (https=)
WO (1) WO2020130146A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20237469B (en) * 2020-11-10 2023-02-10 Dzala Llc Novel compositions for neutralizing toxic effects of hydrogen peroxide in living cells or tissues
CN116456965A (zh) * 2020-12-09 2023-07-18 雀巢产品有限公司 使用至少一种甘氨酸或其衍生物和至少一种大型中性氨基酸和/或阳离子氨基酸或其前体的组合物和方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013175266A1 (en) * 2012-05-21 2013-11-28 Chemi Nutra Inc. Method for increasing muscle mass and strength
US9820504B2 (en) * 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
AU2014225786B2 (en) 2013-03-08 2017-10-12 Axiom Foods, Inc. Rice protein supplements
WO2014191856A1 (en) 2013-05-31 2014-12-04 Nestec S.A. Methods for enhancement of muscle protein synthesis
CN106061479B (zh) * 2014-03-07 2019-04-23 味之素株式会社 虚弱预防剂
JP6496599B2 (ja) * 2014-06-13 2019-04-03 花王株式会社 筋タンパク質合成シグナル活性化剤
JP6848962B2 (ja) * 2016-03-16 2021-03-24 味の素株式会社 行動体力向上剤

Similar Documents

Publication Publication Date Title
JP2014094951A5 (https=)
JP2017519739A5 (https=)
JP2019068829A5 (https=)
JPWO2020130146A5 (https=)
HRP20250541T1 (hr) Isporuka mikro-distrofina s adeno-povezanim virusnim vektorom za liječenje mišićne distrofije
EP4342312A3 (en) Tobacco composition
JP2015131825A5 (https=)
EA201190325A1 (ru) Специфичные к меланокортиновым рецепторам пептиды
NO20083104L (no) Fast preparat
JP2020517703A5 (https=)
JP2016506747A5 (https=)
JP2019520344A5 (https=)
WO2022240379A3 (en) A stable pharmaceutical composition comprising selexipag
CY1115955T1 (el) Ενα στερεο φαρμακευτικο σκευασμα
JP2009521473A5 (https=)
JP2021526021A5 (https=)
JP2018199643A5 (https=)
JP2008540506A5 (https=)
JP2016526379A5 (https=)
CY1113943T1 (el) Παρασκευασμα κατακρατησης 3-(2- διμεθυλαμινομεθυλο-κυκλοεξυλο) φαινολης
AR118985A1 (es) Composición que comprende fibra y proteína
WO2016003158A3 (ko) DX2 단백질과 p14/ARF 단백질 간의 결합을 억제하는 신규 화합물 및 상기 화합물을 유효성분으로 함유하는 암질환 치료 또는 예방용 약학조성물
JPWO2019171843A5 (https=)
JP2019508507A5 (https=)
JP2021123697A5 (https=)